MabCure Inc

Chart & Performance

D1W1MN

No data to show

P/E

—

P/S

0.16

EPS

—

Div Yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

Revenues

500k

Net income

-12m

L+769.12%

CFO

-61k

L-91.13%

Profile

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.

URL

IPO date

Jul 23, 2007

Employees

Domiciled in

Incorporated in

Valuation

No data to show